Efficacy and safety of adjunctive padsevonil in adults with drug-resistant focal epilepsy: Results from two double-blind, randomized, placebo-controlled trials.

Michael Rademacher,Manuel Toledo, Wim Van Paesschen,Kore K Liow,Ivan G Milanov, Maria-Luise Esch, Nan Wang,Merran MacPherson,William J Byrnes, Timothy D C Minh,Elizabeth Webster,Konrad J Werhahn

Epilepsia open（2022）

引用 4|浏览16

暂无评分

摘要

In both trials, the primary outcomes did not reach statistical significance in any PSL dose group compared with placebo. PSL was generally well tolerated, and no new safety signals were identified.

查看译文

关键词

antiepileptic drug,antiseizure medication,dual mechanism of action,focal seizure,synaptic vesicle protein 2,tolerability

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要